Tianxiong Mi
Merck & Co., Inc., Rahway, NJ, USA (United States)
ORCID: 0000-0003-4014-4060Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Indexed papers
Papers
Driven by 9 papers. Top paper: “New, potent, small molecule agonists of tyrosine kinase receptors attenuate dry eye disease”.
Shaon Joy, Tianxiong Mi, Ghasem Yazdanpanah, Kevin Burgess, Cintia S. de Paiva +1 more
Duyen Thi Cam Nguyen, Kevin Burgess, Tianxiong Mi
Siriwalee Siriwibool, Kevin Burgess, Tianxiong Mi
Siriwalee Siriwibool, Kevin Burgess, Tianxiong Mi
Duyen Nguyen, Zhe Gao, Kevin Burgess, Tianxiong Mi
Zhe Gao, Zeynep Mituta, Kevin Burgess, Tianxiong Mi
Tianxiong Mi, Rui-Liang Lyu, Thitima Pewklang, Tye Thompson, Arthur Sefiani +3 more
Kevin Burgess, Tianxiong Mi
Lorenz Mattes, Thitima Pewklang, Karin Hauser, Kevin Burgess, Tianxiong Mi